Institutional investors hold a majority ownership of GILD through the 87.50% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended December 2014, these large investors purchased a net $38.5 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CAPFI DELEN ASSET MANAGEMENT SA Bought 551.9 Thousand shares of Gilead Sciences
ETHENEA INDEPENDENT INVESTORS SA Bought 287.5 Thousand shares of Gilead Sciences